210 results on '"Huang, Tianhua"'
Search Results
2. First and second trimester maternal serum markers for prenatal aneuploidy screening: An update on the adjustment factors for race, smoking, and insulin dependent diabetes mellitus
3. Effects of race and ethnicity on perinatal outcomes in high-income and upper-middle-income countries: an individual participant data meta-analysis of 2 198 655 pregnancies
4. Highly dispersed CeO2–x nanoparticles with rich oxygen vacancies enhance photocatalytic performance of g-C3N4 toward methyl orange degradation under visible light irradiation
5. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia
6. Maternal Ethnicity and the Risk of Obstetrical Anal Sphincter Injury: A Retrospective Cohort Study
7. High calorie diet background alters the expression of sirtuins in the testes of mice under caloric restriction
8. Cytogenetic outcomes following a failed cell-free DNA screen: a population-based retrospective cohort study of 35,146 singleton pregnancies
9. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis
10. Racial/ethnic variations in gestational weight gain : a population-based study in Ontario
11. Racial differences in contribution of prepregnancy obesity and excessive gestational weight gain to large-for-gestational-age neonates
12. Hormone Levels in Pregnancy and Subsequent Risk of Maternal Breast and Ovarian Cancer: A Systematic Review
13. Comparing Maternal Serum Screening Markers Among IVF and Spontaneous Conceptions in Ontario Through Registry Data
14. Enhanced First Trimester Aneuploidy Screening with Placental Growth Factor and Alpha Feto-Protein: Detection of Trisomies 18 and 13
15. Study of equilibrium solution and thermodynamic models in correlation with solubility data of rivastigmine tartrate in (H2O + isopropanol), (H2O + ethanol), and (H2O + acetonitrile) binary solvent mixtures
16. Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies
17. Enhanced First Trimester Screening for Trisomy 21 with Contingent Cell-Free Fetal DNA: A Comparative Performance and Cost Analysis
18. Thermodynamic analysis and calculation of solubility of Memantine hydrochloride in ethanol plus (acetonitrile, water, ethyl acetate) binary solvent mixtures
19. Mitochondrial DNA and genomic DNA ratio in embryo culture medium is not a reliable predictor for in vitro fertilization outcome
20. Prenatal Biochemical Screening and Long Term Risk of Maternal Cardiovascular Disease: Population Based Cohort Study
21. Preimplantation Genetic Screening with Spent Culture Medium/Blastocoel Fluid for in Vitro Fertilization
22. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis†‡
23. First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-β human chorionic gonadotrophin, placental growth factor, and α-fetoprotein
24. First and second trimester maternal serum markers in pregnancies with a vanishing twin
25. Degradation of Reinforced Concrete Beams Subjected to Sustained Loading and Multi-Environmental Factors.
26. The Effects of Electroacupuncture as an Adjunct Therapy on Poststroke Aphasia: A Systematic Review and Meta-Analysis.
27. Maternal diabetes increases apoptosis in mice oocytes, not 2-cell embryos
28. Factors affecting sperm fertilizing capacity in men infected with HIV
29. Response to “On gestational weeks and maths”
30. Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis†
31. The impact of maternal weight discrepancies on prenatal screening results for Down syndrome
32. Accuracy of Down syndrome risks generated by first trimester combined screening and integrated prenatal screening: P2-76
33. Integrated prenatal screening for Down syndrome — Will incorporating magnitude of risk change improve screening performance?: P2-68
34. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome
35. Improving the Fixation Method for Preimplantation Genetic Diagnosis by Fluorescent in Situ Hybridization
36. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening
37. Age-specific risk of fetal loss observed in a second trimester serum screening population
38. Prospective experience with integrated prenatal screening and first trimester combined screening for trisomy 21 in a large Canadian urban center
39. Racial differences in first trimester nuchal translucency
40. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies
41. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: A validation study
42. Contingent screening for Down syndrome
43. Triploidy identified through second-trimester serum screening
44. Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada.
45. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies
46. Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes
47. Risk of Severe Maternal Morbidity or Death in Relation to Prenatal Biochemical Screening: Population-Based Cohort Study.
48. A 2‐year review of publicly funded cell‐free DNA screening in Ontario: utilization and adherence to funding criteria.
49. Fetal growth restriction: First trimester abnormal analytes, second trimester uterine artery—complementary or redundant?
50. 977: Fetal growth restriction: First trimester abnormal analytes, second trimester uterine artery - complementary or redundant?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.